The data from this experiment further elucidated the mechanisms underlying the formation of drug-resistance CML cells, involving three key players: lncRNA MEG3, the regulatory miRNA miR-21, and ABC transporters. The gene discussed is ABCG2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.